FSU Chemists Achieve Landmark Synthesis for Cancer Research

A Florida State University (FSU) chemist, James Frederich, and his team have developed a method to rapidly synthesize complex natural molecules, which may have biomedical applications. Their groundbreaking work, published in the Journal of the American Chemical Society, marks the first full synthesis of fusicoccadiene, a crucial precursor to potential cancer chemotherapy treatments. The Frederich Laboratory focuses on synthesizing complex natural products that are currently inaccessible for practical use, with a particular interest in medicinal applications.

The work marks the first full synthesis of fusicoccadiene, a precursor to potential cancer chemotherapy treatments.

Fusicoccadiene and Its Potential

Fusicoccadiene is a hydrocarbon precursor molecule to fusicoccanes, a family of natural molecules derived from fungi. Several fusicoccanes, including fusicoccin A and cotylenin A, show potential in inducing cell death in cancer cells by sensitizing them to intrinsic death mechanisms.

Synthetic Challenges and Breakthroughs

The structure of fusicoccadiene, characterized by a 5-8-5 ring system (two 5-membered rings fused to a central 8-membered ring), is highly complex and difficult to synthesize in laboratory settings. Frederich noted that realizing the synthetic blueprint was challenging and involved several doctoral thesis projects spanning nearly a decade.

The structure of fusicoccadiene, with its 5-8-5 ring system, is highly complex and difficult to synthesize.

The Synthetic Technique

The Frederich Lab's innovative technique involves:

• Converting a polyene progenitor compound into fusicoccadiene using light to facilitate chemical processes.
• Performing subsequent modifications to alter the molecular structure at precise, site-specific locations.
• This approach allows for the creation of desired compounds and specific spatial arrangements, yielding different functionalities and applications.

The method primarily focuses on the direct construction of the 5-8-5 nucleus early in molecular formation, followed by reactions to functionalize the structure's periphery. The initial polyene progenitor undergoes seven steps of chemical processes to transform into fusicoccadiene.

Significance for Drug Discovery

While transitioning a synthesized molecule into a patient-ready treatment is a lengthy process, research like Frederich's is crucial. These initial steps involve testing various structures, enabling specific functionalities, and modifying natural molecules, thus laying the groundwork for future effective medicines. According to Wei Yang, chair of the Department of Chemistry and Biochemistry, this research significantly contributes to FSU's drug discovery initiatives. The work received vital support from the National Institute of General Medical Sciences and the Warner Herz fund.